| Oct 2, 2025 |
Oct 6, 2025 |
NeueHealth, Inc.
|
Director |
Sell |
26.3
|
-3,840,816
|
-36.79%
|
✗
|
$15.6K |
| Mar 12, 2025 |
Mar 14, 2025 |
BuzzFeed, Inc.
|
10% Owner |
Sell |
20.0
|
-362,966
|
-9.64%
|
✗
|
$798K |
| Mar 7, 2025 |
Mar 11, 2025 |
BuzzFeed, Inc.
|
10% Owner |
Sell |
22.5
|
-47,477
|
-1.25%
|
✗
|
$96.2K |
| Mar 4, 2025 |
Mar 6, 2025 |
BuzzFeed, Inc.
|
10% Owner |
Sell |
36.3
|
-21,531
|
-0.56%
|
✗
|
$44.6K |
| Dec 23, 2024 |
Dec 23, 2024 |
Marker Therapeutics, Inc.
|
10% Owner |
Buy |
100.0
|
+554,250
|
51.73%
|
✗
|
$1.8M |
| Sep 16, 2024 |
Sep 17, 2024 |
MBX Biosciences, Inc.
|
10% Owner |
Buy |
100.0
|
+500,000
|
16.05%
|
✗
|
$8M |
| Apr 22, 2024 |
Apr 24, 2024 |
Korro Bio, Inc.
|
10% Owner |
Buy |
85.0
|
+17,857
|
1.66%
|
✗
|
$1000K |
| Jul 18, 2023 |
Jul 20, 2023 |
Sagimet Biosciences Inc.
|
10% Owner |
Buy |
67.5
|
+29,338
|
0.38%
|
✗
|
$469.4K |
| Jul 17, 2023 |
Jul 19, 2023 |
Savara Inc
|
10% Owner |
Buy |
85.0
|
+333,333
|
1.38%
|
✗
|
$1000K |
| Dec 20, 2022 |
Dec 22, 2022 |
Arcellx, Inc.
|
10% Owner |
Sell |
22.5
|
-2,000,000
|
-29.65%
|
✗
|
$51.2K |
| Jun 21, 2022 |
Jun 23, 2022 |
Arcellx, Inc.
|
10% Owner |
Buy |
93.8
|
+312,500
|
4.86%
|
✗
|
$5M |
| May 26, 2022 |
May 31, 2022 |
IonQ, Inc.
|
10% Owner |
Sell |
15.0
|
-2,922,966
|
-10.00%
|
✗
|
$17.1M |
| Apr 11, 2022 |
Apr 13, 2022 |
Trevi Therapeutics, Inc.
|
10% Owner |
Buy |
100.0
|
+2,631,578
|
33.78%
|
✗
|
$5M |
| Apr 5, 2022 |
Apr 7, 2022 |
Enliven Therapeutics, Inc.
|
10% Owner |
Sell |
20.0
|
-694,551
|
-21.01%
|
✗
|
$751.3K |
| Feb 8, 2022 |
Feb 9, 2022 |
Arcellx, Inc.
|
10% Owner |
Buy |
100.0
|
+1,583,333
|
32.65%
|
✗
|
$23.7M |
| Jan 28, 2022 |
Feb 1, 2022 |
Robinhood Markets, Inc.
|
Director |
Sell |
26.3
|
-23,847,593
|
-33.35%
|
✗
|
$29.6K |
| Jan 21, 2022 |
Jan 25, 2022 |
Enliven Therapeutics, Inc.
|
10% Owner |
Sell |
22.5
|
-134,558
|
-3.91%
|
✗
|
$202.2K |
| Jan 18, 2022 |
Jan 20, 2022 |
Enliven Therapeutics, Inc.
|
10% Owner |
Sell |
36.3
|
-26,555
|
-0.77%
|
✗
|
$48.7K |
| Jan 12, 2022 |
Jan 14, 2022 |
Enliven Therapeutics, Inc.
|
10% Owner |
Sell |
36.3
|
-21,550
|
-0.62%
|
✗
|
$41.8K |
| Jan 7, 2022 |
Jan 11, 2022 |
Enliven Therapeutics, Inc.
|
10% Owner |
Sell |
36.3
|
-18,760
|
-0.53%
|
✗
|
$38.7K |
| Jan 4, 2022 |
Jan 6, 2022 |
Enliven Therapeutics, Inc.
|
10% Owner |
Sell |
32.5
|
-31,916
|
-0.90%
|
✗
|
$72.2K |
| Dec 30, 2021 |
Jan 3, 2022 |
Enliven Therapeutics, Inc.
|
10% Owner |
Sell |
20.0
|
-116,476
|
-3.19%
|
✗
|
$266.9K |
| Dec 27, 2021 |
Dec 29, 2021 |
Enliven Therapeutics, Inc.
|
10% Owner |
Sell |
22.5
|
-67,427
|
-1.81%
|
✗
|
$159.5K |
| Dec 9, 2021 |
Dec 27, 2021 |
ARDELYX, INC.
|
10% Owner |
Sell |
17.5
|
-2,881,570
|
-21.14%
|
✗
|
$3.6M |
| Dec 9, 2021 |
Dec 27, 2021 |
Enliven Therapeutics, Inc.
|
10% Owner |
Sell |
20.0
|
-291,152
|
-7.25%
|
✗
|
$688.5K |
| Jun 28, 2021 |
Jun 30, 2021 |
NeueHealth, Inc.
|
10% Owner |
Buy |
95.0
|
+1,944,444
|
2.78%
|
✗
|
$35M |
| Jun 28, 2021 |
Jun 30, 2021 |
Monte Rosa Therapeutics, Inc.
|
10% Owner |
Buy |
100.0
|
+1,050,000
|
15.81%
|
✗
|
$20M |
| Apr 13, 2021 |
Apr 15, 2021 |
OnKure Therapeutics, Inc.
|
10% Owner |
Buy |
100.0
|
+666,666
|
16.19%
|
✗
|
$10M |
| Mar 16, 2021 |
Mar 18, 2021 |
Marker Therapeutics, Inc.
|
10% Owner |
Buy |
100.0
|
+5,714,285
|
114.29%
|
✗
|
$10M |
| Nov 11, 2020 |
Nov 13, 2020 |
Cloudflare, Inc.
|
10% Owner |
Sell |
17.5
|
-12,133,330
|
-75.95%
|
✗
|
$1.3M |
| Aug 19, 2020 |
Aug 21, 2020 |
Cloudflare, Inc.
|
10% Owner |
Sell |
15.0
|
-456,796
|
-13.97%
|
✗
|
$17.6M |
| Aug 14, 2020 |
Aug 18, 2020 |
Cloudflare, Inc.
|
10% Owner |
Sell |
15.0
|
-410,700
|
-11.16%
|
✗
|
$16.2M |
| Aug 17, 2020 |
Aug 18, 2020 |
Sprout Social, Inc.
|
10% Owner |
Sell |
15.0
|
-3,441,846
|
-38.14%
|
✗
|
$94.7M |
| Aug 11, 2020 |
Aug 13, 2020 |
Cloudflare, Inc.
|
10% Owner |
Sell |
15.0
|
-738,278
|
-16.71%
|
✗
|
$28.4M |
| Aug 7, 2020 |
Aug 10, 2020 |
Cloudflare, Inc.
|
10% Owner |
Sell |
17.5
|
-19,473,349
|
-81.50%
|
✗
|
$3.4M |
| Jul 14, 2020 |
Jul 16, 2020 |
Nkarta, Inc.
|
10% Owner |
Buy |
100.0
|
+666,666
|
29.82%
|
✗
|
$12M |
| Jun 15, 2020 |
Jun 17, 2020 |
ARDELYX, INC.
|
10% Owner |
Sell |
52.5
|
-43
|
0.00%
|
✗
|
$273.9 |
| Jun 10, 2020 |
Jun 12, 2020 |
ARDELYX, INC.
|
10% Owner |
Sell |
20.0
|
-2,499,957
|
-15.50%
|
✗
|
$719K |
| May 19, 2020 |
May 21, 2020 |
Cloudflare, Inc.
|
10% Owner |
Sell |
16.3
|
-5,194,802
|
-55.71%
|
✗
|
$9.6M |
| Apr 13, 2020 |
Apr 14, 2020 |
Mersana Therapeutics, Inc.
|
10% Owner |
Sell |
51.3
|
-3,190
|
-0.04%
|
✗
|
$27.4K |
| Apr 3, 2020 |
Apr 13, 2020 |
Trevi Therapeutics, Inc.
|
10% Owner |
Sell |
52.5
|
-564
|
-0.01%
|
✗
|
$1.5K |
| Apr 9, 2020 |
Apr 13, 2020 |
Mersana Therapeutics, Inc.
|
10% Owner |
Sell |
22.5
|
-3,996,810
|
-33.42%
|
✗
|
$177.8K |
| Aug 28, 2019 |
Apr 13, 2020 |
Mersana Therapeutics, Inc.
|
10% Owner |
Sell |
52.5
|
-1,211
|
-0.01%
|
✗
|
$3.5K |
| Mar 16, 2020 |
Mar 16, 2020 |
Enliven Therapeutics, Inc.
|
10% Owner |
Buy |
100.0
|
+475,000
|
13.42%
|
✗
|
$7.6M |
| Mar 6, 2020 |
Mar 10, 2020 |
CHAMPIONS ONCOLOGY, INC.
|
10% Owner |
Sell |
17.5
|
-708,155
|
-29.24%
|
✗
|
$5M |
| Jan 24, 2020 |
Jan 28, 2020 |
Adaptimmune Therapeutics PLC
|
10% Owner |
Buy |
96.3
|
+7,500,000
|
7.90%
|
✗
|
$5M |
| Nov 12, 2019 |
Nov 12, 2019 |
Galera Therapeutics, Inc.
|
10% Owner |
Buy |
100.0
|
+416,666
|
10.57%
|
✗
|
$5M |
| Jul 22, 2019 |
Jul 24, 2019 |
Mirum Pharmaceuticals, Inc.
|
10% Owner |
Buy |
100.0
|
+450,000
|
12.04%
|
✗
|
$6.8M |
| May 9, 2019 |
May 13, 2019 |
Trevi Therapeutics, Inc.
|
10% Owner |
Buy |
100.0
|
+2,500,000
|
128.96%
|
✗
|
$25M |
| Mar 5, 2019 |
Mar 6, 2019 |
Mersana Therapeutics, Inc.
|
10% Owner |
Buy |
100.0
|
+3,750,000
|
46.07%
|
✗
|
$15M |
| Sep 7, 2018 |
Sep 10, 2018 |
Adaptimmune Therapeutics PLC
|
10% Owner |
Buy |
100.0
|
+15,000,000
|
18.76%
|
✗
|
$25M |
| Mar 26, 2018 |
Mar 28, 2018 |
Adaptimmune Therapeutics PLC
|
10% Owner |
Buy |
97.5
|
+6,571,164
|
8.95%
|
✗
|
$12.6M |
| Mar 21, 2018 |
Mar 23, 2018 |
Adaptimmune Therapeutics PLC
|
10% Owner |
Buy |
87.5
|
+1,268,508
|
1.76%
|
✗
|
$2.4M |
| Feb 26, 2018 |
Feb 27, 2018 |
Oruka Therapeutics, Inc.
|
10% Owner |
Sell |
20.0
|
-1,460,209
|
-100.00%
|
✗
|
$731.3K |
| Nov 27, 2017 |
Nov 27, 2017 |
APPIAN CORP
|
10% Owner |
Sell |
15.0
|
-569,620
|
-100.00%
|
✗
|
$11.1M |
| Nov 20, 2017 |
Nov 21, 2017 |
APPIAN CORP
|
10% Owner |
Sell |
15.0
|
-2,820,516
|
-100.00%
|
✗
|
$55M |
| Oct 10, 2017 |
Oct 10, 2017 |
RHYTHM PHARMACEUTICALS, INC.
|
10% Owner |
Buy |
100.0
|
+550,000
|
12.61%
|
✗
|
$9.4M |
| Aug 30, 2017 |
Aug 31, 2017 |
ARDELYX, INC.
|
10% Owner |
Sell |
52.5
|
-485
|
0.00%
|
✗
|
$2.4K |
| Jul 3, 2017 |
Jul 6, 2017 |
Mersana Therapeutics, Inc.
|
10% Owner |
Buy |
100.0
|
+1,000,000
|
14.01%
|
✗
|
$15M |
| Mar 27, 2017 |
Mar 28, 2017 |
Adaptimmune Therapeutics PLC
|
10% Owner |
Buy |
100.0
|
+12,870,000
|
21.71%
|
✗
|
$9M |
| Jul 18, 2016 |
Jul 20, 2016 |
ARDELYX, INC.
|
10% Owner |
Buy |
100.0
|
+2,290,951
|
19.43%
|
✗
|
$20M |
| Jan 13, 2016 |
Jan 14, 2016 |
ARDELYX, INC.
|
10% Owner |
Buy |
100.0
|
+1,500,000
|
14.57%
|
✗
|
$15M |
| Oct 5, 2015 |
Oct 6, 2015 |
SYNLOGIC, INC.
|
10% Owner |
Buy |
100.0
|
+1,146,308
|
21.08%
|
✗
|
$6M |
| Jun 17, 2015 |
Jun 19, 2015 |
SUPERNUS PHARMACEUTICALS, INC.
|
10% Owner |
Sell |
17.5
|
-111,881
|
-1.44%
|
✗
|
$1.8M |
| Jun 15, 2015 |
Jun 17, 2015 |
SUPERNUS PHARMACEUTICALS, INC.
|
10% Owner |
Sell |
17.5
|
-2,888,119
|
-27.14%
|
✗
|
$1.9M |
| Jun 5, 2015 |
Jun 9, 2015 |
ARDELYX, INC.
|
10% Owner |
Buy |
100.0
|
+4,672,897
|
83.14%
|
✗
|
$50M |
| Dec 23, 2014 |
Dec 29, 2014 |
ARDELYX, INC.
|
10% Owner |
Sell |
51.3
|
-9,515
|
-0.17%
|
✗
|
$42K |
| Aug 27, 2014 |
Aug 29, 2014 |
Viracta Therapeutics, Inc.
|
10% Owner |
Sell |
17.5
|
-266,700
|
-5.41%
|
✗
|
$2.1M |
| Aug 8, 2014 |
Aug 12, 2014 |
Viracta Therapeutics, Inc.
|
10% Owner |
Sell |
17.5
|
-710,540
|
-12.61%
|
✗
|
$4.7M |
| Jan 15, 2014 |
Jan 15, 2014 |
CRESCENT BIOPHARMA, INC.
|
10% Owner |
Buy |
100.0
|
+512,500
|
14.31%
|
✗
|
$4.1M |
| Jun 30, 2010 |
Jul 2, 2010 |
Viracta Therapeutics, Inc.
|
10% Owner |
Buy |
100.0
|
+23,824,451
|
100.00%
|
✗
|
$6.6M |